Cerenome, Inc.(CNSY)

Medical - Pharmaceuticals · Houston, TX

$1.59+0.03 (+1.92%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T22:26:20.153Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:26:20.153Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 10,944,145
TTM free cash flow · period ending 2026-06-30: -23,549,000

FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNSY Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

CNSY Competitors' Price/FCF Ratio

CNSY

Cerenome, Inc.

Current

Market Cap

$10.94M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs CNSY

Market Cap

$11.00M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs CNSY

Market Cap

$11.02M

Price/FCF Ratio

N/A

TTM Avg

5.33

3Y Avg

5.33

5Y Avg

5.33

BIVI

BioVie Inc.

vs CNSY

Market Cap

$10.86M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRZ

Polyrizon Ltd.

vs CNSY

Market Cap

$10.83M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.08M

Price/FCF Ratio

N/A

TTM Avg

6.98

3Y Avg

6.98

5Y Avg

6.98

VTGN

VistaGen Therapeutics, Inc.

vs CNSY

Market Cap

$11.12M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs CNSY

Market Cap

$10.68M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs CNSY

Market Cap

$11.36M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs CNSY

Market Cap

$10.45M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Cerenome, Inc. (CNSY)	$10.94M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$11.00M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.02M	N/A	5.33	5.33	5.33
BioVie Inc. (BIVI)vs ›	$10.86M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.83M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.08M	N/A	6.98	6.98	6.98
VistaGen Therapeutics, Inc. (VTGN)vs ›	$11.12M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$10.68M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$11.36M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$10.45M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

CNSY Price/FCF Ratio Metrics

CNSY Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics